ComputChem is a technology company focused on in silico covalent drug discovery design and lead optimization within the clean energy sector. The company aims to translate computational chemistry research into innovative drug discovery solutions. As a portfolio company of Early Charm Drug Design, ComputChem has received its latest grant investment from the Maryland Innovation Initiative (MII) on 29 March 2023. Based in the United States, ComputChem demonstrates potential for advancements in the intersection of computational chemistry and drug discovery, attracting attention from investors and researchers alike.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | Unknown | 1 | Maryland Innovation Initiative (MII) | 29 Mar 2023 |
No recent news or press coverage available for ComputChem.